It is my pleasure to invite you to the 2022 In-person meeting of the Israeli Society of Gene and Cell Therapy (ISGCT 2022), set to take place in Tel-Aviv, on February 10th, 2022.
Gene and Cell therapy are finally taking center stage in global health. No longer a futuristic dream of the hopeful few but rather a true revolutionary reality, with several drugs already on the market and hundreds of advanced clinical trials. We can proudly reflect on the important role of Israeli researchers in the rising of the field, with seminal contributions to stem cell research, T cell engineering, genome editing, liver gene therapy and so much more.
Remaining challenges are nevertheless formidable. How can we improve delivery and prolong the effect? How can we increase therapeutic potency while providing safety? How can we devise new remedies for the yet incurable devastating human ailments, and do so in a scalable and affordable manner?
Meeting these challenges will require the innovation and dedication of individual researchers, but it will also depend on nourishing strong scientific communities. The Israeli Society of Gene and Cell therapy has thus set as its goals to support the sharing of data and ideas, promote collaborations, address common challenges and advance clinical translation.
In the upcoming 2022 ISGCT meeting, we are privileged to have Professor Juan Carlos Izpisua Belmonte give a Keynote lecture. We are also most excited by the impressive list of speakers from the Israeli academia, clinic and industry, destined to make this event a great boost for our rejuvenating society. Please do join us at the 2022 ISGCT meeting.
Adi Barzel, PhD, Tel Aviv University,
President of Israeli Society of Gene and Cell Therapy
Adi Barzel Dinorah Friedmann-Morvinski Ayal Hendel